EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Treatment of Primary Solid Renal Tumours Using Histotripsy: Study Protocol for the CAIN Feasibility Trial

Tze Min Wah, Joseph F Amaral, Paul F Laeseke

CardioVascular and Interventional Radiology · 2025

DOI: 10.1007/s00270-025-04035-5 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift CardioVascular and Interventional Radiology, 2025. Verfasst von Tze Min Wah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic and Interventional Radiology, Leeds Teaching Hospitals Trust and Leeds Institute of Medical Research, University of Leeds, Leeds, West Yor…. Hauptthemen laut MEDLINE: High-Intensity Focused Ultrasound Ablation, Kidney Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HistoSonics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose The purpose of this prospective, multi-centre, single-arm feasibility trial is to evaluate the technical success and safety profile of the HistoSonics System for the treatment of primary solid renal tumours using histotripsy. Methods/design The CAIN trial will enrol up to 20 patients with a non-metastatic solid renal tumour ≤ 3 cm treated with histotripsy. Histotripsy is a non-thermal and non-ionizing mechanical process of tissue destruction resulting from the targeted delivery of focused ultrasound pulses. The primary endpoints are technical success and freedom from index procedure related major complications. Technical success is defined as complete coverage of the tumour as determined ≤ 36 h post-index procedure by contrast-enhanced magnetic resonance imaging (MRI) or computerized tomography (CT). An index procedure related major complication is defined as Clavien-Dindo Classification Grade 3 or higher up to 30 days after the last histotripsy procedure. Treated patients will have a follow-up visit performed at 14 days, 30 days, 90 days, and 180 days post-procedure. Trial Registration : Clinicaltrials.gov identifier NCT05432232 & NIHR CRN CPMS 53429. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Intensity Focused Ultrasound AblationKidney NeoplasmsFemaleHumansMaleMiddle AgedContrast MediaFeasibility StudiesMagnetic Resonance ImagingProspective StudiesTomography, X-Ray ComputedTreatment Outcome

Stichwörter der Autor:innen

ComplicationsHistotripsyImage guided ablationKidney cancerNon-thermal ablationTechnical successUltrasound

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Diagnostic and Interventional Radiology, Leeds Teaching Hospitals Trust and Leeds Institute of Medical Research, University of Leeds, Leeds, West Yorkshire, UK. tze.wah@nhs.net.
  • Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Department of Radiology, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
  • Department of Biomedical Engineering, University of Wisconsin - Madison, Madison, WI, USA.

Förderung

  • HistoSonics

Zitieren

APA

Wah, T. M., Amaral, J. F., & Laeseke, P. F. (2025). Treatment of Primary Solid Renal Tumours Using Histotripsy: Study Protocol for the CAIN Feasibility Trial. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-025-04035-5

Vancouver

Wah TM, Amaral JF, Laeseke PF. Treatment of Primary Solid Renal Tumours Using Histotripsy: Study Protocol for the CAIN Feasibility Trial. CardioVascular and Interventional Radiology. 2025. doi:10.1007/s00270-025-04035-5

BibTeX
@article{Wah2025,
  author = {Wah, Tze Min and Amaral, Joseph F and Laeseke, Paul F},
  title = {Treatment of Primary Solid Renal Tumours Using Histotripsy: Study Protocol for the CAIN Feasibility Trial},
  journal = {CardioVascular and Interventional Radiology},
  year = {2025},
  doi = {10.1007/s00270-025-04035-5}
}
Kostenlos starten →